Morgan Stanley’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
|
|||||
2023
Q1 | $5 | Sell |
|
|||||
2022
Q4 | $234 | Sell |
|
|||||
2022
Q3 | $11K | Hold |
|
|||||
2022
Q2 | $18K | Sell |
|
|||||
2022
Q1 | $29K | Sell |
|
|||||
2021
Q4 | $51K | Hold |
|
|||||
2021
Q3 | $89K | Hold |
|
|||||
2021
Q2 | $142K | Buy |
|
|||||
2021
Q1 | $1K | Buy |
|
|||||
2020
Q4 | $0 | Hold |
|
|||||
2020
Q3 | $0 | Buy |
|
|||||
2020
Q1 | – | Sell |
|
|||||
2019
Q4 | $0 | Hold |
|
|||||
2019
Q3 | $0 | Sell |
|
|||||
2019
Q2 | $0 | Sell |
|
|||||
2019
Q1 | $3K | Sell |
|
|||||
2018
Q4 | $3K | Sell |
|
|||||
2018
Q3 | $20K | Sell |
|
|||||
2018
Q2 | $17K | Buy |
|
|||||
2018
Q1 | $27K | Hold |
|
|||||
2017
Q4 | $30K | Sell |
|
|||||
2017
Q3 | $49K | Sell |
|
|||||
2017
Q2 | $74K | Sell |
|
|||||
2017
Q1 | $82K | Buy |
|
|||||
2016
Q4 | $24K | Sell |
|
|||||
2016
Q3 | $37K | Buy |
|
|||||
2016
Q2 | $40K | Sell |
|
|||||
2016
Q1 | $63K | Buy |
|
|||||
2015
Q4 | $67K | Sell |
|
|||||
2015
Q3 | $167K | Sell |
|
|||||
2015
Q2 | $266K | Buy |
|
|||||
2015
Q1 | $46K | Buy |
|
|||||
2014
Q4 | $17K | Sell |
|
|||||
2014
Q3 | $54K | Sell |
|
|||||
2014
Q2 | $205K | Buy |
|
|||||
2014
Q1 | $206K | Buy |
|
|||||
2013
Q4 | $88K | Sell |
|
|||||
2013
Q3 | $333K | Buy |
|